Reliance Global (RELI) 10-Q 18 May 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 18, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-40020
Entity Registrant Name	RELIANCE GLOBAL GROUP, INC.
Entity Central Index Key	0001812727
Entity Tax Identification Number	46-3390293
Entity Incorporation, State or Country Code	FL
Entity Address, Address Line One	300 Blvd. of the Americas
Entity Address, Address Line Two	Suite 105
Entity Address, City or Town	Lakewood
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08701
City Area Code	732
Local Phone Number	380-4600
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,631,048
Common Stock [Member]
Title of 12(b) Security	Common Stock
Trading Symbol	RELI
Security Exchange Name	NASDAQ
Series A Warrants [Member]
Title of 12(b) Security	Series A Warrants
Trading Symbol	RELIW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 2,116,333	$ 505,410
Restricted cash	1,437,961	1,404,359
Other receivables		11,464
Prepaid expense and other current assets	164,154	245,535
Current assets - discontinued operations	7,354	85,998
Total current assets	4,707,763	3,265,379
Property and equipment, net	155,511	162,767
Right-of-use assets	921,531	1,018,952
Investment in NSURE, Inc.	900,000	900,000
Intangibles, net	12,889,277	9,085,092
Goodwill	14,287,099	14,287,099
Other non-current assets	23,285	23,284
Other assets - discontinued operations		9,685,156
Total assets	33,884,466	38,427,729
Current liabilities:
Accounts payable and other accrued liabilities	1,076,612	951,382
Short term financing agreements	38,312	106,817
Other payables	1,182,055	1,476,113
Current portion of long-term debt	1,235,052	1,118,721
Current portion of leases payable	312,549	339,937
Earn-out liability, current portion	1,555,692	2,153,478
Current liabilities - discontinued operations	50,228	1,647,836
Total current liabilities	5,450,500	7,794,284
Loans payable, related parties, less current portion	$ 958,743	$ 1,669,515
Other Liability, Noncurrent, Related and Nonrelated Party Status [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Long term debt, less current portion	$ 12,035,753	$ 12,349,673
Leases payable, less current portion	638,937	714,068
Earn-out liability, less current portion	398,000	556,000
Warrant liabilities	2,166,919	6,433,150
Non-current liabilities - discontinued operations
Total liabilities	21,648,852	29,516,690
Stockholders’ equity:
Preferred stock, $0.086 par value; 750,000,000 shares authorized and 0 issued and outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.086 par value; 133,333,333 shares authorized and 1,566,048 and 1,219,573 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	134,660	104,883
Additional paid-in capital	40,881,475	35,798,139
Stock subscription receivable
Accumulated deficit	(28,780,521)	(26,991,983)
Total stockholders’ equity	12,235,614	8,911,039
Total liabilities and stockholders’ equity	33,884,466	38,427,729
Nonrelated Party [Member]
Current assets:
Accounts receivable, related parties	970,345	994,321
Related Party [Member]
Current assets:
Accounts receivable, related parties	$ 11,616	$ 18,292

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share		$ 0.086
Preferred Stock, Shares Authorized		750,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.086	$ 0.086
Common stock, shares authorized	133,333,333	133,333,333
Common stock, shares issued	1,566,048	1,219,573
Common stock, shares outstanding	1,566,048	1,219,573

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue
Commission income	$ 3,939,103	$ 3,058,697
Total revenue	3,939,103	3,058,697
Operating expenses
Commission expense	1,083,326	785,611
Salaries and wages	1,712,097	1,631,813
General and administrative expenses	1,358,254	2,333,795
Marketing and advertising	136,572	89,529
Depreciation and amortization	541,873	468,278
Total operating expenses	4,832,122	5,309,026
Loss from operations	(893,019)	(2,250,329)
Other income
Other expense, net	(389,351)	(107,751)
Recognition and change in fair value of warrant liabilities	4,266,231	11,845,964
Total other income	3,876,880	11,738,213
Income from continuing operations	2,983,861	9,487,884
Loss from discontinued operations	(4,772,399)	(147,884)
Net (loss) income	$ (1,788,538)	$ 9,340,000
Basic (loss) earnings per share
Continuing operations	$ 1.92	$ 2.61
Discontinued operations	(3.07)	(0.15)
Basic (loss) earnings per share	(1.15)	2.46
Diluted loss per share
Continuing operations	(0.59)	(9.57)
Discontinued operations	(2.18)	(0.12)
Diluted loss per share	$ (2.77)	$ (9.69)
Weighted average number of shares outstanding - basic	1,553,953	980,569
Weighted average number of shares outstanding - diluted	2,185,847	1,195,480

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Common Stock Issuable [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021		$ 62,815		$ 27,329,201	$ (20,000,000)	$ (33,458,145)	$ (26,066,129)
Balance, shares at Dec. 31, 2021		730,407	0
Share-based compensation				739,960			739,960
Net (loss) income						9,340,000	9,340,000
Shares issued due to private placement	$ 781	$ 15,313		(16,043)	20,000,000		20,000,051
Shares issued due to private placement, shares	9,076	178,059
Shares issued pursuant to acquisition of Medigap		$ 3,475		4,759,976			4,763,451
Shares issued pursuant to acquisition of Medigap, shares		40,402
Exercise of Series A warrants		$ 2,150		2,472,850			2,475,000
Exercise of Series A warrants, shares		25,000
Issuance of prefunded Series C warrants in exchange for common shares		$ (18,788)		18,788
Issuance of prefunded Series C Warrants in exchange for common shares, shares		(218,462)
Shares issued for vested stock awards		$ 34		(34)
Shares issued for vested stock awards, shares		400
Balance at Mar. 31, 2022	$ 781	$ 64,999		35,304,698		(24,118,145)	11,252,333
Balance, shares at Mar. 31, 2022	9,076	755,807	0
Balance at Dec. 31, 2022		$ 104,883		35,798,139		(26,991,983)	8,911,039
Balance, shares at Dec. 31, 2022		1,219,573
Share-based compensation				43,797			43,797
Common shares issued for earnout liability		$ 9,404		973,074			982,478
Common shares issued to settle earnout liability, shares		109,358
Common shares issued for Yes Americana loan		$ 5,740		$ 639,260			$ 645,000
Common shares issued to settle loan - Yes Americana, shares		66,743
Share round up due to reverse split		1,300		(5,946)			(4,646)
Share round up due to reverse split, shares		15,336
Shares issued for private placement		$ 13,333		$ 3,433,151			$ 3,446,484
Private placement of shares		155,038
Net (loss) income						(1,788,538)	(1,788,538)
Balance at Mar. 31, 2023		$ 134,660		$ 40,881,475		$ (28,780,521)	$ 12,235,614
Balance, shares at Mar. 31, 2023		1,566,048					262,684

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (1,788,538)	$ 9,340,000
Adjustment to reconcile net income to net cash used in operating activities:
Depreciation and amortization	541,873	468,279
Amortization of debt issuance costs and accretion of debt discount	11,721	6,467
Non-cash lease expense	(5,098)	2,597
Stock compensation expense	43,797	739,960
Recognition and change in fair value of warrant liability	(4,266,231)	(11,845,964)
Earn-out fair value and write-off adjustments	476,692	407,071
Change in fair value of warrant liability
Change in operating assets and liabilities:
Accounts payables and other accrued liabilities	125,229	(1,875,191)
Accounts receivable	23,976	(48,228)
Accounts receivable, related parties	6,676	5,489
Other receivables	11,464	(4,361)
Other payables	(294,058)	(1,998)
Other non-current assets		(52,992)
Prepaid expense and other current assets	81,381	2,220,963
Net cash used in continuing operating activities	(5,031,116)	(637,908)
Net cash adjustments for discontinued operating activities	3,966,238	294,628
Total net cash used in continuing and discontinued operating activities	(1,064,878)	(343,280)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(6,695)
Purchase of intangibles	(73,894)	(249,235)
Net cash used in investing activities	(80,589)	(249,235)
Net cash used in discontinued investing activities	(15,708)	(18,142,858)
Total net cash used in continuing and discontinued investing activities	(96,297)	(18,392,093)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal repayments of debt	(207,580)	(227,172)
Repayments on short term financing	(98,004)
Proceeds from loans payable, related parties	345,000
Payments on loans payable, related parties	(412,500)	(10,770)
Payments of earn-out liabilities	(250,000)
Proceeds from exercise of warrants into common stock		2,475,000
Proceeds from private placement of shares and warrants	3,446,484	17,853,351
Net cash provided by continuing financing activities	2,823,400	20,090,409
Net cash used in discontinued financing activities	(17,700)
Total net cash provided by continuing and discontinued financing activities	2,805,700	20,090,409
Net increase in cash and restricted cash	1,644,525	1,355,036
Cash and restricted cash at beginning of year	1,909,769	4,620,722
Cash and restricted cash at end of year	3,554,294	5,975,758
SUPPLEMENTAL DISCLOSURE OF CASH AND NON-CASH TRANSACTIONS:
Cash paid for interest	382,410	105,447
Common stock issuance to repay related party liability	645,000
Common stock issuance to settle earn-out liabilities	982,478
Private placement equity financing costs	552,618
Issuance of Series D Warrants		6,930,335
Issuance of placement agent warrants		1,525,923
Conversion of common stock into Series C Warrants		281,815
Common stock issued pursuant to acquisition		$ 4,763,451

SUMMARY OF BUSINESS AND SIGNIFI

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES Reliance Global Group, Inc., formerly known as Ethos Media Network, Inc. (“RELI”, “Reliance”, or the “Company”), was incorporated in Florida on August 2, 2013. Basis of Presentation and Principles of Consolidation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Liquidity As of March 31, 2023, the Company’s reported cash and restricted cash aggregated balance was approximately $ 3,554,000 4,708,000 5,451,000 742,000 12,236,000 893,000 4,266,000 2,984,000 4,772,000 1,789,000 3,446,000 Although there can be no assurance that debt or equity financing will be available on acceptable terms, the Company believes its financial position and its ability to raise capital to be reasonable and sufficient. Based on our assessment, we do not believe there are conditions or events that, in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year of filing these financial statements with the Securities and Exchange Commission (“SEC”). Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates. Cash and Restricted Cash Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows: SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW March 31, 2023 March 31, 2022 Cash $ 2,116,333 $ 5,491,407 Restricted cash 1,437,961 484,351 Total cash and restricted cash $ 3,554,294 $ 5,975,758 Fair Value of Financial Instruments Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities; Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk. Warrant Liabilities: SCHEDULE OF EARN OUT LIABILITY March 31, 2023 December 31, 2022 Stock price $ 3.01 $ 8.55 Volatility 105.0 % 105.0 % Time to expiry 3.76 4.01 Dividend yield 0 % 0 % Risk free rate 3.7 % 4.1 % The following reconciles fair value of the liability classified warrants: SCHEDULE OF RECONCILES WARRANT COMMITMENT Series B Warrant Commitment Series B Warrant Liabilities Placement Agent Warrants Total Beginning balance, December 31, 2021 $ 37,652,808 $ - $ - $ 37,652,808 Initial recognition - 55,061,119 1,525,924 56,587,043 Unrealized loss (gain) 17,408,311 (48,668,869 ) (1,477,024 ) (32,737,582 ) Warrants exercised or transferred (55,061,119 ) (8,000 ) - (55,069,119 ) Ending balance, December 31, 2022 $ - $ 6,384,250 $ 48,900 $ 6,433,150 Unrealized (gain) loss - $ (4,226,950 ) $ (39,281 ) $ (4,266,231 ) Ending balance, March 31, 2023 $ - $ 2,157,300 $ 9,619 $ 2,166,919 Earn-out liabilities: SCHEDULE OF FAIR VALUE MEASUREMENTS March 31, 2023 December 31, 2022 Valuation technique Discounted cash flow Discounted cash flow Significant unobservable input Projected revenue and probability of achievement Projected revenue and probability of achievement The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs: SCHEDULE OF EARN OUT LIABILITY March 31, 2023 WACC Risk Premium: 13.5 % Volatility 50 % Credit Spread: 13 % Payment Delay (days) 90 Risk free rate USD Yield Curve Discounting Convention: Mid-period Number of Iterations 100,000 Undiscounted remaining earn out payments were approximately $ 2,123,442 SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE March 31, 2023 December 31, 2022 Beginning balance – January 1 $ 2,709,478 $ 3,813,878 Acquisitions and settlements (1,232,478 ) (1,104,925 ) Period adjustments: Fair value changes included in earnings * 476,692 525 Ending balance $ 1,953,692 $ 2,709,478 Less: Current portion (1,555,692 ) (2,153,478 ) Ending balance, less current portion 398,000 556,000 * Recorded as a reduction to general and administrative expenses Revenue Recognition The following table disaggregates the Company’s revenue by line of business, showing commissions earned: SCHEDULE OF DISAGGREGATION REVENUE Three Months ended March 31, 2023 Medical/Life Property and Casualty Total Regular EBS $ 237,380 $ - $ 237,380 USBA 12,029 - 12,029 CCS/UIS - 46,770 46,770 Montana 490,994 - 490,994 Fortman 306,270 208,145 514,415 Altruis 1,868,136 - 1,868,136 Kush 320,291 - 320,291 Barra 94,707 354,381 449,088 Total $ 3,329,807 $ 609,296 $ 3,939,103 Three Months ended March 31, 2022 Medical/Life Property and Casualty Total Regular EBS $ 221,184 $ - $ 221,184 USBA 13,587 - 13,587 CCS/UIS - 43,881 43,881 Montana 506,721 - 506,721 Fortman 332,600 197,260 529,860 Altruis 1,304,872 - 1,304,872 Kush 438,592 - 438,592 Revenue $ 2,817,556 $ 241,141 $ 3,058,697 The following are customers representing 10% or more of total revenue: SCHEDULE OF CONCENTRATIONS OF REVENUES Three Months ended March 31, Insurance Carrier 2023 2022 Priority Health 43 % 32 % BlueCross BlueShield 13 % 13 % Insurance Carrier 13 % 13 % No other single customer accounted for more than 10 Income Taxes The Company recorded no income tax expense for the three months ended March 31, 2023 and 2022 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives. As of March 31, 2023 Discontinued Operations The Company’s board of directors approved the discontinuation of Medigap Healthcare Insurance Company, LLC (“Medigap”), a subsidiary of the Company, effective April 17, 2023, due to Medigap’s sustained recurring losses stemming from amongst other factors, greater than anticipated revenue chargebacks. Aside for retaining certain assets of Medigap that have continued use to the Company, Medigap’s assets were considered impaired and the Company recognized a net of estimated liability adjustments loss of $ 4.4 million, presented in discontinued operations in the consolidated statement of operations for the period ended March 31, 2023. The Company does not expect further continuing involvement with Medigap, and in accordance with ASC 205-20-45-9, no corporate overhead has been allocated to discontinued operations. Recently Issued Accounting Pronouncements We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 2. GOODWILL AND OTHER INTANGIBLE ASSETS The following table rolls forward the Company’s goodwill balance for the periods ending March 31, 2023 and December 31, 2022. SCHEDULE OF IMPAIRMENT OF GOODWILL Goodwill December 31, 2021 $ 10,050,277 Goodwill recognized in connection with Barra acquisition on April 26, 2022 4,236,822 December 31, 2022 14,287,099 March 31, 2023 $ 14,287,099 The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of March 31, 2023: SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD Weighted Average Remaining Amortization period (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade name and trademarks 2.3 $ 1,807,188 $ (1,056,995 ) $ 750,193 Internally developed software 3.9 1,723,780 (373,580 ) 1,350,200 Customer relationships 7.5 11,922,290 (2,355,705 ) 9,566,585 Purchased software 3.7 665,136 (592,312 ) 72,824 Video Production Assets 0 50,000 (50,000 ) - Non-competition agreements 1.6 3,504,810 (2,355,335 ) 1,149,475 $ 19,673,204 $ (6,783,927 ) $ 12,889,277 The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2022: Weighted Average Remaining Amortization period (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade name and trademarks 2.5 $ 1,806,188 $ (969,241 ) $ 836,947 Internally developed software 4.2 1,529,018 (269,786 ) 1,259,232 Customer relationships 7.8 7,372,290 (1,708,767 ) 5,663,523 Purchased software 0 562,327 (562,327 ) - Video Production Assets 0 50,000 (50,000 ) - Non-competition agreements 1.9 3,504,810 (2,179,420 ) 1,325,390 $ 14,824,633 $ (5,739,541 ) $ 9,085,092 The following table reflects expected amortization expense as of March 31, 2023, for each of the following five years and thereafter: SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS Years ending December 31, Amortization Expense 2023 (remainder of year) $ 1,914,714 2024 2,177,765 2025 1,783,809 2026 1,515,517 2027 1,182,581 Thereafter 4,314,891 Total $ 12,889,277

LONG-TERM DEBT AND SHORT-TERM F

LONG-TERM DEBT AND SHORT-TERM FINANCINGS	3 Months Ended
	Mar. 31, 2023
Long-term Debt And Short-term Financings
LONG-TERM DEBT AND SHORT-TERM FINANCINGS	NOTE 3. LONG-TERM DEBT AND SHORT-TERM FINANCINGS Long-Term Debt The composition of the long-term debt follows: SCHEDULE OF LONG TERM DEBT March 31, 2023 December 31, 2022 Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $11,833 and $12,388 as of March 31, 2023 and December 31, 2022, respectively $ 412,763 $ 426,883 Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, variable interest of Prime Rate plus 2.5 August 2028 11,833 12,388 $ 412,763 $ 426,883 Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, variable interest of Prime Rate plus 1.5 December 2028 14,438 15,076 671,685 693,682 Oak Street Funding LLC Term Loan for the acquisition of SWMT, variable interest of Prime Rate plus 2.0 April 2029 8,837 9,206 765,592 788,596 Oak Street Funding LLC Term Loan for the acquisition of FIS, variable interest of Prime Rate plus 2.0 May 2029 35,389 36,843 1,931,005 1,987,846 Oak Street Funding LLC Term Loan for the acquisition of ABC, variable interest of Prime Rate plus 2.0 September 2029 40,509 42,129 3,162,591 3,249,575 Oak Street Funding LLC Term Loan for the acquisition of Barra, variable interest of Prime Rate plus 2.5 May 2032 192,831 198,188 6,327,169 6,321,812 13,270,805 13,468,394 Less: current portion (1,235,052 ) (1,118,721 ) Long-term debt $ 12,035,753 $ 12,349,673 Oak Street Funding LLC – Term Loans and Credit Facilities SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES Fiscal year ending December 31, Maturities of Long-Term Debt 2023 (remainder of year) $ 893,877 2024 1,411,275 2025 1,567,542 2026 1,736,878 2027 1,924,523 Thereafter 6,040,548 Total 13,574,643 Less: debt issuance costs (303,838 ) Total $ 13,270,805 Short-Term Financings The Company has various short-term notes payable for financed items such as insurance premiums and CRM software purchases. Total financed for the quarters ended March 31, 2023, and 2022, respectively, was approximately $ 154,000 and $ 0 . These are normally paid in equal installments over a period of twelve months or less and carry interest rates ranging between 0 % and 8 % per annum. As of March 31, 2023 and 2022, respectively, approximately $ 38,000 and $ 0 remained outstanding on short-term financings.

WARRANT LIABILITIES

WARRANT LIABILITIES	3 Months Ended
	Mar. 31, 2023
Warrant Liabilities
WARRANT LIABILITIES	NOTE 4. WARRANT LIABILITIES Series B Warrants Pursuant to the terms of the SPA, during the quarter ended March 31, 2023, the Series B Warrants’ effective exercise price reset to $ 3.55 1,331,667 For the periods ended March 31, 2023 and 2022, net fair value gains and losses recognized for the Series B Warrants were $ 4,226,950 12,425,426 2,157,300 6,384,250 Placement Agent Warrants For the periods ended March 31, 2023 and 2022, net fair value gains and losses recognized for the Placement Agent Warrants (“PAW”) were, a gain of $ 39,281 579,463, 9,619 48,900,

EQUITY

EQUITY	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
EQUITY	NOTE 5. EQUITY Common Stock The Company is authorized to issue 133,333,333 0.086 On February 23, 2023, pursuant to authority granted by the Board of Directors of the Company, the Company implemented a 1-for-15 reverse split 15,300 1,300 In March of 2023 Yes Americana, a related party, converted $ 645,000 66,743 9.67 66,743 In March of 2023 the company issued 155,038 As of March 31, 2023 and December 31, 2022, there were 1,566,048 1,219,573 Warrants Series A Warrants In conjunction with the Company’s initial public offering, the Company issued 138,000 0.15 110 99.00 25,000 113,000 Series E and F Warrants On March 13, 2023, the Company entered into a securities purchase agreement (the “SPA-2023”) with one institutional buyer for the purchase and sale of, (i) an aggregate of 155,038 0.086 897,594 2,105,264 52,632 entered into a registration rights agreement with the buyer to register for resale the common shares underlying the Series E and F Warrants. The aggregate purchase price for the Common Shares, Prefunded Warrants (Series E Warrants) and the Common Warrants (Series F Warrants) to be purchased by the Buyer shall be equal to (i) $ 3.80 3.799 0.001 The Common Warrant (Series F) has an exercise price of $ 3.55 . The Common Warrant will be exercisable six months following the date of issuance and will expire five and a half years from the date of issuance. 3.91 The closing of the Private Placement-2023 occurred on March 16, 2023. EF Hutton, a division of Benchmark Investments, LLC (the “Placement Agent”) acted as the sole placement agent and was entitled to an 8 Gross and net proceeds to the Company from the were approximately $ 4 3.4 553,000 The Company determined the Series E Warrants, Series F Warrants, and PA Warrants are equity in nature because of provisions, pursuant to the warrant agreements, that permit the holder to obtain a fixed number of shares for a fixed monetary amount. The values offset to $ 0 Equity -based Compensation During the period ending March 31, 2023, an executive was awarded an annual stock award in conjunction with a promotion agreement, consisting of 2,667 5,842 Total stock-based compensation expense recorded in general and administrative expenses in the condensed consolidated statements of operations for the periods ended March 31, 2023 and 2022 was $ 43,797 739,960

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	NOTE 6. EARNINGS (LOSS) PER SHARE Basic earnings per common share (“EPS”) applicable to common stockholders is computed by dividing earnings applicable to common stockholders by the weighted-average number of common shares outstanding. If there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available to common stockholders, diluted EPS would be computed in the same manner as basic EPS. The following calculates basic and diluted EPS: SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS Three Months Three Months Ended Ended March 31, 2023 March 31, 2022 Income from continuing operations $ 2,983,861 $ 9,487,884 Deemed dividend - (6,930,335 ) Net income continuing operations, numerator, basic computation 2,983,861 2,557,549 Recognition and change in fair value of warrant liabilities (4,266,231 ) (13,992,664 ) Net loss continuing operations, numerator, diluted computation $ (1,282,370 ) $ (11,435,115 ) Weighted average common shares, basic 1,553,953 980,569 Effect of series B warrants 631,894 214,911 Weighted average common shares, dilutive 2,185,847 1,195,480 Earnings (loss) per common share – basic $ 1.92 $ 2.61 Earnings (loss) per common share – diluted (0.59 ) (9.57 ) The reversal of the gain on the change fair value of the Series B warrant liability for the three months March 31, 2023 and 2022 is included in the numerator of the dilutive EPS calculation to eliminate the effects the warrants as the impact is dilutive. SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARES March 31, 2023 March 31, 2022 For the Three Months Ended March 31, 2023 March 31, 2022 Shares subject to outstanding common stock options 10,928 10,928 Shares subject to outstanding Series A warrants 113,000 113,000 Shares subject to outstanding Series F warrants 2,105,264 - Shares subject to placement agent warrants 52,632 - Shares subject to unvested stock awards 7,709 661 Shares subject to conversion of Series B preferred stock - 147,939

LEASES

LEASES	3 Months Ended
	Mar. 31, 2023
Leases
LEASES	NOTE 7. LEASES Operating lease expense for the three months ended March 31, 2023 and 2022 was $ 161,614 145,662, 3.85 5.60 Future minimum lease payment under these operating leases consisted of the following: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT Period ending March 31, 2023 Operating Lease Obligations 2023 $ 271,267 2024 269,908 2025 144,124 2026 113,738 2027 117,150 Thereafter 151,052 Total undiscounted operating lease payments 1,067,239 Less: Imputed interest 115,753 Present value of operating lease liabilities $ 951,486

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8. COMMITMENTS AND CONTINGENCIES Legal Contingencies The Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal contingencies are accrued as of March 31, 2023 and December 31, 2022. Litigation relating to the insurance brokerage industry is not uncommon. As such the Company, from time to time have been subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the future. Earn-out liabilities The following outlines changes to the Company’s earn-out liability balances for the respective periods ended March 31, 2023 and December 31, 2022: SCHEDULE OF EARN-OUT LIABILITY Fortman Montana Altruis Kush Barra Total Ending balance December 31, 2022 $ 667,000 $ 500,000 $ 834,943 $ 147,535 $ 560,000 $ 2,709,478 Changes due to payments - (250,000 ) (834,943 ) (147,535 ) - (1,232,478 ) Changes due to fair value adjustments 394,467 150,000 94,225 - (162,000 ) 476,692 Ending balance March 31, 2023 $ 1,061,467 $ 400,000 $ 94,225 $ - $ 398,000 $ 1,953,692 Fortman Montana Altruis Kush Barra Total Ending balance December 31, 2021 $ 515,308 $ 615,969 $ 992,868 $ 1,689,733 $ - $ 3,813,878 Changes due to business combinations - - - - 600,000 600,000 Changes due to payments (34,430 ) (326,935 ) (84,473 ) (1,259,087 ) - (1,704,925 ) Changes due to fair value adjustments 186,122 210,966 (73,452 ) (283,111 ) (40,000 ) 525 Ending balance December 31, 2022 $ 667,000 $ 500,000 $ 834,943 $ 147,535 $ 560,000 $ 2,709,478

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9. RELATED PARTY TRANSACTIONS On September 13, 2022, the Company issued a promissory note to YES Americana Group, LLC, (Americana) a related party entity for the principal sum of $ 1,500,000 On February 7, 2023, the Company and Americana entered into an amendment to the Note pursuant to which (i) the principal amount of the Note was increased to $ 1,845,000 0.086 On February 13, 2023, Americana effectuated a conversion of $ 645,000 66,743 0.086 400,000 800,000

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10. SUBSEQUENT EVENTS During April 2023, the Company sold its remaining 262,684 900,000 262,684 zero

SUMMARY OF BUSINESS AND SIGNI_2

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Liquidity	Liquidity As of March 31, 2023, the Company’s reported cash and restricted cash aggregated balance was approximately $ 3,554,000 4,708,000 5,451,000 742,000 12,236,000 893,000 4,266,000 2,984,000 4,772,000 1,789,000 3,446,000 Although there can be no assurance that debt or equity financing will be available on acceptable terms, the Company believes its financial position and its ability to raise capital to be reasonable and sufficient. Based on our assessment, we do not believe there are conditions or events that, in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year of filing these financial statements with the Securities and Exchange Commission (“SEC”).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.
Cash and Restricted Cash	Cash and Restricted Cash Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows: SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW March 31, 2023 March 31, 2022 Cash $ 2,116,333 $ 5,491,407 Restricted cash 1,437,961 484,351 Total cash and restricted cash $ 3,554,294 $ 5,975,758
Fair Value of Financial Instruments	Fair Value of Financial Instruments Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities; Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk. Warrant Liabilities: SCHEDULE OF EARN OUT LIABILITY March 31, 2023 December 31, 2022 Stock price $ 3.01 $ 8.55 Volatility 105.0 % 105.0 % Time to expiry 3.76 4.01 Dividend yield 0 % 0 % Risk free rate 3.7 % 4.1 % The following reconciles fair value of the liability classified warrants: SCHEDULE OF RECONCILES WARRANT COMMITMENT Series B Warrant Commitment Series B Warrant Liabilities Placement Agent Warrants Total Beginning balance, December 31, 2021 $ 37,652,808 $ - $ - $ 37,652,808 Initial recognition - 55,061,119 1,525,924 56,587,043 Unrealized loss (gain) 17,408,311 (48,668,869 ) (1,477,024 ) (32,737,582 ) Warrants exercised or transferred (55,061,119 ) (8,000 ) - (55,069,119 ) Ending balance, December 31, 2022 $ - $ 6,384,250 $ 48,900 $ 6,433,150 Unrealized (gain) loss - $ (4,226,950 ) $ (39,281 ) $ (4,266,231 ) Ending balance, March 31, 2023 $ - $ 2,157,300 $ 9,619 $ 2,166,919 Earn-out liabilities: SCHEDULE OF FAIR VALUE MEASUREMENTS March 31, 2023 December 31, 2022 Valuation technique Discounted cash flow Discounted cash flow Significant unobservable input Projected revenue and probability of achievement Projected revenue and probability of achievement The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs: SCHEDULE OF EARN OUT LIABILITY March 31, 2023 WACC Risk Premium: 13.5 % Volatility 50 % Credit Spread: 13 % Payment Delay (days) 90 Risk free rate USD Yield Curve Discounting Convention: Mid-period Number of Iterations 100,000 Undiscounted remaining earn out payments were approximately $ 2,123,442 SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE March 31, 2023 December 31, 2022 Beginning balance – January 1 $ 2,709,478 $ 3,813,878 Acquisitions and settlements (1,232,478 ) (1,104,925 ) Period adjustments: Fair value changes included in earnings * 476,692 525 Ending balance $ 1,953,692 $ 2,709,478 Less: Current portion (1,555,692 ) (2,153,478 ) Ending balance, less current portion 398,000 556,000 * Recorded as a reduction to general and administrative expenses
Investment, Policy [Policy Text Block]
Revenue Recognition	Revenue Recognition The following table disaggregates the Company’s revenue by line of business, showing commissions earned: SCHEDULE OF DISAGGREGATION REVENUE Three Months ended March 31, 2023 Medical/Life Property and Casualty Total Regular EBS $ 237,380 $ - $ 237,380 USBA 12,029 - 12,029 CCS/UIS - 46,770 46,770 Montana 490,994 - 490,994 Fortman 306,270 208,145 514,415 Altruis 1,868,136 - 1,868,136 Kush 320,291 - 320,291 Barra 94,707 354,381 449,088 Total $ 3,329,807 $ 609,296 $ 3,939,103 Three Months ended March 31, 2022 Medical/Life Property and Casualty Total Regular EBS $ 221,184 $ - $ 221,184 USBA 13,587 - 13,587 CCS/UIS - 43,881 43,881 Montana 506,721 - 506,721 Fortman 332,600 197,260 529,860 Altruis 1,304,872 - 1,304,872 Kush 438,592 - 438,592 Revenue $ 2,817,556 $ 241,141 $ 3,058,697 The following are customers representing 10% or more of total revenue: SCHEDULE OF CONCENTRATIONS OF REVENUES Three Months ended March 31, Insurance Carrier 2023 2022 Priority Health 43 % 32 % BlueCross BlueShield 13 % 13 % Insurance Carrier 13 % 13 % No other single customer accounted for more than 10
Income Taxes	Income Taxes The Company recorded no income tax expense for the three months ended March 31, 2023 and 2022 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives. As of March 31, 2023
Discontinued Operations	Discontinued Operations The Company’s board of directors approved the discontinuation of Medigap Healthcare Insurance Company, LLC (“Medigap”), a subsidiary of the Company, effective April 17, 2023, due to Medigap’s sustained recurring losses stemming from amongst other factors, greater than anticipated revenue chargebacks. Aside for retaining certain assets of Medigap that have continued use to the Company, Medigap’s assets were considered impaired and the Company recognized a net of estimated liability adjustments loss of $ 4.4 million, presented in discontinued operations in the consolidated statement of operations for the period ended March 31, 2023. The Company does not expect further continuing involvement with Medigap, and in accordance with ASC 205-20-45-9, no corporate overhead has been allocated to discontinued operations.
[custom:PriorPeriodAdjustmentPolicyTextBlock]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.

SUMMARY OF BUSINESS AND SIGNI_3

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2023
Platform Operator, Crypto-Asset [Line Items]
SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW	Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows: SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW March 31, 2023 March 31, 2022 Cash $ 2,116,333 $ 5,491,407 Restricted cash 1,437,961 484,351 Total cash and restricted cash $ 3,554,294 $ 5,975,758
SCHEDULE OF EARN OUT LIABILITY	SCHEDULE OF EARN OUT LIABILITY March 31, 2023 December 31, 2022 Stock price $ 3.01 $ 8.55 Volatility 105.0 % 105.0 % Time to expiry 3.76 4.01 Dividend yield 0 % 0 % Risk free rate 3.7 % 4.1 %
SCHEDULE OF RECONCILES WARRANT COMMITMENT	The following reconciles fair value of the liability classified warrants: SCHEDULE OF RECONCILES WARRANT COMMITMENT Series B Warrant Commitment Series B Warrant Liabilities Placement Agent Warrants Total Beginning balance, December 31, 2021 $ 37,652,808 $ - $ - $ 37,652,808 Initial recognition - 55,061,119 1,525,924 56,587,043 Unrealized loss (gain) 17,408,311 (48,668,869 ) (1,477,024 ) (32,737,582 ) Warrants exercised or transferred (55,061,119 ) (8,000 ) - (55,069,119 ) Ending balance, December 31, 2022 $ - $ 6,384,250 $ 48,900 $ 6,433,150 Unrealized (gain) loss - $ (4,226,950 ) $ (39,281 ) $ (4,266,231 ) Ending balance, March 31, 2023 $ - $ 2,157,300 $ 9,619 $ 2,166,919
SCHEDULE OF FAIR VALUE MEASUREMENTS	SCHEDULE OF FAIR VALUE MEASUREMENTS March 31, 2023 December 31, 2022 Valuation technique Discounted cash flow Discounted cash flow Significant unobservable input Projected revenue and probability of achievement Projected revenue and probability of achievement
SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE	SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE March 31, 2023 December 31, 2022 Beginning balance – January 1 $ 2,709,478 $ 3,813,878 Acquisitions and settlements (1,232,478 ) (1,104,925 ) Period adjustments: Fair value changes included in earnings * 476,692 525 Ending balance $ 1,953,692 $ 2,709,478 Less: Current portion (1,555,692 ) (2,153,478 ) Ending balance, less current portion 398,000 556,000 * Recorded as a reduction to general and administrative expenses
SCHEDULE OF DISAGGREGATION REVENUE	The following table disaggregates the Company’s revenue by line of business, showing commissions earned: SCHEDULE OF DISAGGREGATION REVENUE Three Months ended March 31, 2023 Medical/Life Property and Casualty Total Regular EBS $ 237,380 $ - $ 237,380 USBA 12,029 - 12,029 CCS/UIS - 46,770 46,770 Montana 490,994 - 490,994 Fortman 306,270 208,145 514,415 Altruis 1,868,136 - 1,868,136 Kush 320,291 - 320,291 Barra 94,707 354,381 449,088 Total $ 3,329,807 $ 609,296 $ 3,939,103 Three Months ended March 31, 2022 Medical/Life Property and Casualty Total Regular EBS $ 221,184 $ - $ 221,184 USBA 13,587 - 13,587 CCS/UIS - 43,881 43,881 Montana 506,721 - 506,721 Fortman 332,600 197,260 529,860 Altruis 1,304,872 - 1,304,872 Kush 438,592 - 438,592 Revenue $ 2,817,556 $ 241,141 $ 3,058,697
SCHEDULE OF CONCENTRATIONS OF REVENUES	The following are customers representing 10% or more of total revenue: SCHEDULE OF CONCENTRATIONS OF REVENUES Three Months ended March 31, Insurance Carrier 2023 2022 Priority Health 43 % 32 % BlueCross BlueShield 13 % 13 % Insurance Carrier 13 % 13 %
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
SCHEDULE OF EARN OUT LIABILITY	The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs: SCHEDULE OF EARN OUT LIABILITY March 31, 2023 WACC Risk Premium: 13.5 % Volatility 50 % Credit Spread: 13 % Payment Delay (days) 90 Risk free rate USD Yield Curve Discounting Convention: Mid-period Number of Iterations 100,000

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
SCHEDULE OF IMPAIRMENT OF GOODWILL	The following table rolls forward the Company’s goodwill balance for the periods ending March 31, 2023 and December 31, 2022. SCHEDULE OF IMPAIRMENT OF GOODWILL Goodwill December 31, 2021 $ 10,050,277 Goodwill recognized in connection with Barra acquisition on April 26, 2022 4,236,822 December 31, 2022 14,287,099 March 31, 2023 $ 14,287,099
SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD	The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of March 31, 2023: SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD Weighted Average Remaining Amortization period (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade name and trademarks 2.3 $ 1,807,188 $ (1,056,995 ) $ 750,193 Internally developed software 3.9 1,723,780 (373,580 ) 1,350,200 Customer relationships 7.5 11,922,290 (2,355,705 ) 9,566,585 Purchased software 3.7 665,136 (592,312 ) 72,824 Video Production Assets 0 50,000 (50,000 ) - Non-competition agreements 1.6 3,504,810 (2,355,335 ) 1,149,475 $ 19,673,204 $ (6,783,927 ) $ 12,889,277 The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2022: Weighted Average Remaining Amortization period (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Trade name and trademarks 2.5 $ 1,806,188 $ (969,241 ) $ 836,947 Internally developed software 4.2 1,529,018 (269,786 ) 1,259,232 Customer relationships 7.8 7,372,290 (1,708,767 ) 5,663,523 Purchased software 0 562,327 (562,327 ) - Video Production Assets 0 50,000 (50,000 ) - Non-competition agreements 1.9 3,504,810 (2,179,420 ) 1,325,390 $ 14,824,633 $ (5,739,541 ) $ 9,085,092
SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS	The following table reflects expected amortization expense as of March 31, 2023, for each of the following five years and thereafter: SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS Years ending December 31, Amortization Expense 2023 (remainder of year) $ 1,914,714 2024 2,177,765 2025 1,783,809 2026 1,515,517 2027 1,182,581 Thereafter 4,314,891 Total $ 12,889,277

LONG-TERM DEBT AND SHORT-TERM_2

LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)	3 Months Ended
	Mar. 31, 2023
Long-term Debt And Short-term Financings
SCHEDULE OF LONG TERM DEBT	The composition of the long-term debt follows: SCHEDULE OF LONG TERM DEBT March 31, 2023 December 31, 2022 Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $11,833 and $12,388 as of March 31, 2023 and December 31, 2022, respectively $ 412,763 $ 426,883 Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, variable interest of Prime Rate plus 2.5 August 2028 11,833 12,388 $ 412,763 $ 426,883 Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, variable interest of Prime Rate plus 1.5 December 2028 14,438 15,076 671,685 693,682 Oak Street Funding LLC Term Loan for the acquisition of SWMT, variable interest of Prime Rate plus 2.0 April 2029 8,837 9,206 765,592 788,596 Oak Street Funding LLC Term Loan for the acquisition of FIS, variable interest of Prime Rate plus 2.0 May 2029 35,389 36,843 1,931,005 1,987,846 Oak Street Funding LLC Term Loan for the acquisition of ABC, variable interest of Prime Rate plus 2.0 September 2029 40,509 42,129 3,162,591 3,249,575 Oak Street Funding LLC Term Loan for the acquisition of Barra, variable interest of Prime Rate plus 2.5 May 2032 192,831 198,188 6,327,169 6,321,812 13,270,805 13,468,394 Less: current portion (1,235,052 ) (1,118,721 ) Long-term debt $ 12,035,753 $ 12,349,673
SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES	SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES Fiscal year ending December 31, Maturities of Long-Term Debt 2023 (remainder of year) $ 893,877 2024 1,411,275 2025 1,567,542 2026 1,736,878 2027 1,924,523 Thereafter 6,040,548 Total 13,574,643 Less: debt issuance costs (303,838 ) Total $ 13,270,805

EARNINGS (LOSS) PER SHARE (Tabl

EARNINGS (LOSS) PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS	The following calculates basic and diluted EPS: SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS Three Months Three Months Ended Ended March 31, 2023 March 31, 2022 Income from continuing operations $ 2,983,861 $ 9,487,884 Deemed dividend - (6,930,335 ) Net income continuing operations, numerator, basic computation 2,983,861 2,557,549 Recognition and change in fair value of warrant liabilities (4,266,231 ) (13,992,664 ) Net loss continuing operations, numerator, diluted computation $ (1,282,370 ) $ (11,435,115 ) Weighted average common shares, basic 1,553,953 980,569 Effect of series B warrants 631,894 214,911 Weighted average common shares, dilutive 2,185,847 1,195,480 Earnings (loss) per common share – basic $ 1.92 $ 2.61 Earnings (loss) per common share – diluted (0.59 ) (9.57 )
SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARES	SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARES March 31, 2023 March 31, 2022 For the Three Months Ended March 31, 2023 March 31, 2022 Shares subject to outstanding common stock options 10,928 10,928 Shares subject to outstanding Series A warrants 113,000 113,000 Shares subject to outstanding Series F warrants 2,105,264 - Shares subject to placement agent warrants 52,632 - Shares subject to unvested stock awards 7,709 661 Shares subject to conversion of Series B preferred stock - 147,939

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2023
Leases
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT	Future minimum lease payment under these operating leases consisted of the following: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT Period ending March 31, 2023 Operating Lease Obligations 2023 $ 271,267 2024 269,908 2025 144,124 2026 113,738 2027 117,150 Thereafter 151,052 Total undiscounted operating lease payments 1,067,239 Less: Imputed interest 115,753 Present value of operating lease liabilities $ 951,486

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF EARN-OUT LIABILITY	The following outlines changes to the Company’s earn-out liability balances for the respective periods ended March 31, 2023 and December 31, 2022: SCHEDULE OF EARN-OUT LIABILITY Fortman Montana Altruis Kush Barra Total Ending balance December 31, 2022 $ 667,000 $ 500,000 $ 834,943 $ 147,535 $ 560,000 $ 2,709,478 Changes due to payments - (250,000 ) (834,943 ) (147,535 ) - (1,232,478 ) Changes due to fair value adjustments 394,467 150,000 94,225 - (162,000 ) 476,692 Ending balance March 31, 2023 $ 1,061,467 $ 400,000 $ 94,225 $ - $ 398,000 $ 1,953,692 Fortman Montana Altruis Kush Barra Total Ending balance December 31, 2021 $ 515,308 $ 615,969 $ 992,868 $ 1,689,733 $ - $ 3,813,878 Changes due to business combinations - - - - 600,000 600,000 Changes due to payments (34,430 ) (326,935 ) (84,473 ) (1,259,087 ) - (1,704,925 ) Changes due to fair value adjustments 186,122 210,966 (73,452 ) (283,111 ) (40,000 ) 525 Ending balance December 31, 2022 $ 667,000 $ 500,000 $ 834,943 $ 147,535 $ 560,000 $ 2,709,478

SCHEDULE OF RESTRICTED CASH IN

SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Accounting Policies [Abstract]
Cash	$ 2,116,333	$ 505,410	$ 5,491,407
Restricted cash	1,437,961	$ 1,404,359	484,351
Total cash and restricted cash	$ 3,554,294		$ 5,975,758

SCHEDULE OF EARN OUT LIABILITY

SCHEDULE OF EARN OUT LIABILITY (Details)	3 Months Ended
	Mar. 31, 2023 shares	Dec. 31, 2022
Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free rate	USD Yield Curve
Discounting Convention	Mid-period
Number of iterations	100,000
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	3.01	8.55
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	105	105
Measurement Input, Price Volatility [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	50
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	3 years 9 months 3 days	4 years 3 days
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	0	0
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	3.7	4.1
WACC Risk Premium [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	13.5
Credit Spread [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	13
Payment Delay (Days) [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Earn out liability	90 days

SCHEDULE OF RECONCILES WARRANT

SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Offsetting Assets [Line Items]
Ending balance, December 31, 2022	$ 6,433,150	$ 37,652,808	$ 37,652,808
Initial recognition			56,587,043
Unrealized loss (gain)	4,266,231		(32,737,582)
Warrants exercised or transferred			(55,069,119)
Unrealized (gain) loss	(4,266,231)		32,737,582
Ending balance, March 31, 2023	2,166,919		6,433,150
Series B Warrant Commitment [Member]
Offsetting Assets [Line Items]
Ending balance, December 31, 2022		37,652,808	37,652,808
Initial recognition
Unrealized loss (gain)			17,408,311
Warrants exercised or transferred			(55,061,119)
Unrealized (gain) loss			(17,408,311)
Ending balance, March 31, 2023
Series B Warrant Liabilities [Member]
Offsetting Assets [Line Items]
Ending balance, December 31, 2022	6,384,250
Initial recognition			55,061,119
Unrealized loss (gain)	4,226,950		(48,668,869)
Warrants exercised or transferred			(8,000)
Unrealized (gain) loss	(4,226,950)		48,668,869
Ending balance, March 31, 2023	2,157,300		6,384,250
Placement Agent Warrants [Member]
Offsetting Assets [Line Items]
Ending balance, December 31, 2022	48,900
Initial recognition			1,525,924
Unrealized loss (gain)	39,281	579,463	(1,477,024)
Warrants exercised or transferred
Unrealized (gain) loss	(39,281)	$ (579,463)	1,477,024
Ending balance, March 31, 2023	$ 9,619		$ 48,900

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENTS (Details) - Fair Value, Inputs, Level 3 [Member]	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]
Valuation technique	Discounted cash flow	Discounted cash flow
Significant unobservable input	Projected revenue and probability of achievement	Projected revenue and probability of achievement

SCHEDULE OF GAIN OR LOSSES RECO

SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details) - USD ($)		3 Months Ended	12 Months Ended
		Mar. 31, 2023	Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]
Beginning balance – January 1		$ 2,709,478	$ 3,813,878
Ending balance		1,953,692	2,709,478
Less: Current portion		(1,555,692)	(2,153,478)
Ending balance, less current portion		398,000	556,000
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Beginning balance – January 1		2,709,478	3,813,878
Acquisitions and settlements		(1,232,478)	(1,104,925)
Fair value changes included in earnings	[1]	476,692	525
Ending balance		$ 1,953,692	$ 2,709,478
[1]Recorded as a reduction to general and administrative expenses

SCHEDULE OF DISAGGREGATION REVE

SCHEDULE OF DISAGGREGATION REVENUE (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2021
Product Information [Line Items]
Revenue	$ 3,939,103	$ 3,058,697
Employee Benefits Solutions L L C [Member]
Product Information [Line Items]
Revenue	237,380	221,184
U S Benefits Alliance L L C [Member]
Product Information [Line Items]
Revenue	12,029	13,587
Commercial Coverage Solutions L L C [Member]
Product Information [Line Items]
Revenue	46,770	43,881
Southwestern Montana Financial Center Inc [Member]
Product Information [Line Items]
Revenue	490,994	506,721
Fortman Insurance Services L L C [Member]
Product Information [Line Items]
Revenue	514,415	529,860
Altruis Benefits Consulting Inc [Member]
Product Information [Line Items]
Revenue	1,868,136	1,304,872
Kush [Member]
Product Information [Line Items]
Revenue	320,291	438,592
Barra [Member]
Product Information [Line Items]
Revenue	449,088
Medical/Life [Member] | Regular [Member]
Product Information [Line Items]
Revenue	3,329,807	2,817,556
Medical/Life [Member] | Regular [Member] | Employee Benefits Solutions L L C [Member]
Product Information [Line Items]
Revenue	237,380	221,184
Medical/Life [Member] | Regular [Member] | U S Benefits Alliance L L C [Member]
Product Information [Line Items]
Revenue	12,029	13,587
Medical/Life [Member] | Regular [Member] | Commercial Coverage Solutions L L C [Member]
Product Information [Line Items]
Revenue
Medical/Life [Member] | Regular [Member] | Southwestern Montana Financial Center Inc [Member]
Product Information [Line Items]
Revenue	490,994	506,721
Medical/Life [Member] | Regular [Member] | Fortman Insurance Services L L C [Member]
Product Information [Line Items]
Revenue	306,270	332,600
Medical/Life [Member] | Regular [Member] | Altruis Benefits Consulting Inc [Member]
Product Information [Line Items]
Revenue	1,868,136	1,304,872
Medical/Life [Member] | Regular [Member] | Kush [Member]
Product Information [Line Items]
Revenue	320,291	438,592
Medical/Life [Member] | Regular [Member] | Barra [Member]
Product Information [Line Items]
Revenue	94,707
Property and Casualty [Member] | Regular [Member]
Product Information [Line Items]
Revenue	609,296	241,141
Property and Casualty [Member] | Regular [Member] | Employee Benefits Solutions L L C [Member]
Product Information [Line Items]
Revenue
Property and Casualty [Member] | Regular [Member] | U S Benefits Alliance L L C [Member]
Product Information [Line Items]
Revenue
Property and Casualty [Member] | Regular [Member] | Commercial Coverage Solutions L L C [Member]
Product Information [Line Items]
Revenue	46,770	43,881
Property and Casualty [Member] | Regular [Member] | Southwestern Montana Financial Center Inc [Member]
Product Information [Line Items]
Revenue
Property and Casualty [Member] | Regular [Member] | Fortman Insurance Services L L C [Member]
Product Information [Line Items]
Revenue	208,145	197,260
Property and Casualty [Member] | Regular [Member] | Altruis Benefits Consulting Inc [Member]
Product Information [Line Items]
Revenue
Property and Casualty [Member] | Regular [Member] | Kush [Member]
Product Information [Line Items]
Revenue
Property and Casualty [Member] | Regular [Member] | Barra [Member]
Product Information [Line Items]
Revenue	$ 354,381

SCHEDULE OF CONCENTRATIONS OF R

SCHEDULE OF CONCENTRATIONS OF REVENUES (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Priority Health [Member]
Product Information [Line Items]
Insurance Carrier	43%	32%
Blue Cross Blue Shield [Member]
Product Information [Line Items]
Insurance Carrier	13%	13%

SUMMARY OF BUSINESS AND SIGNI_4

SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Product Information [Line Items]
Restricted Cash and Cash Equivalents	$ 3,554,000	$ 3,554,000
Assets, Current	4,707,763	4,707,763		$ 3,265,379
Liabilities, Current	5,450,500	5,450,500		7,794,284
Working capital deficiency	742,000	742,000
Equity, Attributable to Parent	12,235,614	12,235,614	$ 11,252,333	$ 8,911,039	$ (26,066,129)
Operating Income (Loss)		893,019	2,250,329
Derivative, Gain (Loss) on Derivative, Net		4,266,000
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent		2,983,861	9,487,884
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent		4,772,000
Net loss		1,788,538	$ (9,340,000)
[custom:NetProceedsFromPrivatePlacementIssuanceOfValueAndWarrant]	3,446,000
Earn out payments	$ 2,123,442	2,123,442
Medigap Healthcare Insurance Company LLC [Member] | Discontinued Operations [Member]
Product Information [Line Items]
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$ 4,400,000
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer [Member]
Product Information [Line Items]
Concentration Risk, Percentage		10%

SCHEDULE OF IMPAIRMENT OF GOODW

SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Goodwill Beginning	$ 10,050,277
Goodwill	14,287,099
Barra [Member]
Restructuring Cost and Reserve [Line Items]
Goodwill acquired during period	$ 4,236,822

SCHEDULE OF INTANGIBLE ASSETS A

SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 19,673,204	$ 14,824,633
Accumulated Amortization	(6,783,927)	(5,739,541)
Net Carrying Amount	12,889,277	$ 9,085,092
Gross carrying amount	$ 12,889,277
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	2 years 3 months 18 days	2 years 6 months
Gross Carrying Amount	$ 1,807,188	$ 1,806,188
Accumulated Amortization	(1,056,995)	(969,241)
Net Carrying Amount	$ 750,193
Gross carrying amount		$ 836,947
Internally Developed Software [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	3 years 10 months 24 days	4 years 2 months 12 days
Gross Carrying Amount	$ 1,723,780	$ 1,529,018
Accumulated Amortization	(373,580)	(269,786)
Net Carrying Amount	$ 1,350,200
Gross carrying amount		$ 1,259,232
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	7 years 6 months	7 years 9 months 18 days
Gross Carrying Amount	$ 11,922,290	$ 7,372,290
Accumulated Amortization	(2,355,705)	(1,708,767)
Net Carrying Amount	$ 9,566,585
Gross carrying amount		$ 5,663,523
Purchased Software [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	3 years 8 months 12 days	0 years
Gross Carrying Amount	$ 665,136	$ 562,327
Accumulated Amortization	(592,312)	(562,327)
Net Carrying Amount	$ 72,824
Gross carrying amount
Video Production Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	0 years	0 years
Gross Carrying Amount	$ 50,000	$ 50,000
Accumulated Amortization	(50,000)	(50,000)
Net Carrying Amount
Gross carrying amount
Non-competition Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	1 year 7 months 6 days	1 year 10 months 24 days
Gross Carrying Amount	$ 3,504,810	$ 3,504,810
Accumulated Amortization	(2,355,335)	(2,179,420)
Net Carrying Amount	$ 1,149,475
Gross carrying amount		$ 1,325,390

SCHEDULE OF AMORTIZATION EXPENS

SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)	Mar. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remainder of year)	$ 1,914,714
2024	2,177,765
2025	1,783,809
2026	1,515,517
2027	1,182,581
Thereafter	4,314,891
Total	$ 12,889,277

SCHEDULE OF LONG TERM DEBT (Det

SCHEDULE OF LONG TERM DEBT (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Line of Credit Facility [Line Items]
Long term debt current	$ 13,270,805	$ 13,468,394
Long term debt current	(1,235,052)	(1,118,721)
Long term debt current	12,035,753	12,349,673
SWMT [Member]
Line of Credit Facility [Line Items]
Long term debt current	765,592	788,596
FIS [Member]
Line of Credit Facility [Line Items]
Long term debt current	1,931,005	1,987,846
ABC [Member]
Line of Credit Facility [Line Items]
Long term debt current	3,162,591	3,249,575
Barra [Member]
Line of Credit Facility [Line Items]
Long term debt current	6,327,169	6,321,812
EBS and USBA [Member]
Line of Credit Facility [Line Items]
Long term debt current	412,763	426,883
CCS [Member]
Line of Credit Facility [Line Items]
Long term debt current	$ 671,685	$ 693,682

SCHEDULE OF LONG TERM DEBT (D_2

SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
SWMT [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	2%
Maturity date	April 2029
Net of deferred financing cost	$ 8,837	$ 9,206
FIS [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	2%
Maturity date	May 2029
Net of deferred financing cost	$ 35,389	36,843
ABC [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	2%
Maturity date	September 2029
Net of deferred financing cost	$ 40,509	42,129
Barra [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	2.50%
Maturity date	May 2032
Net of deferred financing cost	$ 192,831	198,188
EBS and USBA [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	2.50%
Maturity date	August 2028
Net of deferred financing cost	$ 11,833	12,388
CCS [Member]
Line of Credit Facility [Line Items]
Variable interest of prime rate plus	1.50%
Maturity date	December 2028
Net of deferred financing cost	$ 14,438	$ 15,076

SCHEDULE OF CUMULATIVE MATURITI

SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Long-term Debt And Short-term Financings
2023 (remainder of year)	$ 893,877
2024	1,411,275
2025	1,567,542
2026	1,736,878
2027	1,924,523
Thereafter	6,040,548
Total	13,574,643
Less: debt issuance costs	(303,838)
Total	$ 13,270,805	$ 13,468,394

LONG-TERM DEBT AND SHORT-TERM_3

LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative) - USD ($)	Mar. 31, 2023	Mar. 31, 2022
Long-term Debt And Short-term Financings
Debt Instrument, Face Amount	$ 154,000	$ 0
Debt Instrument, Interest Rate, Stated Percentage	0%	8%
Short-Term Bank Loans and Notes Payable	$ 38,000	$ 0

WARRANT LIABILITIES (Details Na

WARRANT LIABILITIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Mar. 13, 2023
Offsetting Assets [Line Items]
Exercise price	$ 0.15			$ 0.001
Net fair value gains losses	$ 4,266,231		$ (32,737,582)
Series B Warrants [Member]
Offsetting Assets [Line Items]
Exercise price	$ 3.55
Series B Warrant [Member]
Offsetting Assets [Line Items]
Number of shares issued	1,331,667
Series B Warrant Liabilities [Member]
Offsetting Assets [Line Items]
Net fair value gains losses	$ 4,226,950	$ 12,425,426
Warrant liability	2,157,300		6,384,250
Placement Agent Warrants [Member]
Offsetting Assets [Line Items]
Net fair value gains losses	39,281	$ 579,463	(1,477,024)
Warrant liability	$ 9,619		$ 48,900

EQUITY (Details Narrative)

EQUITY (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended
	Mar. 16, 2023	Mar. 13, 2023	Feb. 23, 2023	Mar. 13, 2022	Mar. 31, 2023	Jan. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Mar. 01, 2023	Jan. 13, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized					133,333,333		133,333,333				133,333,333
Common stock, par value					$ 0.086		$ 0.086				$ 0.086
Stockholders' equity, reverse stock split			1-for-15 reverse split
Common stock, shares outstanding					1,566,048		1,566,048				1,219,573
Warrents exercise price		$ 0.001			$ 0.15		$ 0.15
Gross proceeds cash fee	$ 8
Proceeds from issuance of debt							$ 4,000,000
Proceeds from issuance of debt							3,400,000
Direct finnacing fee							553,000
Additional paid in capital					$ 40,881,475		40,881,475				$ 35,798,139
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures							2,667
Share-Based Payment Arrangement, Expense							5,842
Stock compensation expense							43,797	$ 739,960
Warrant Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Additional paid in capital					0		$ 0
Series E [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares, acquisitions				2,105,264
Series F [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, shares, acquisitions				52,632
Americana [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt conversion original debt amount					$ 645,000
Debt Conversion converted instrument shares					66,743
Debt instrument convertible conversion price									$ 9.67
Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of common stock warrant					138,000		138,000
Warrents exercise price					$ 99		$ 99
Exercise price percentage					110%		110%
Exercise of series A warrants, shares							113,000
Series E Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrents exercise price		3.55
Series E Warrants [Member] | Common Unit [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrents exercise price		3.80
Series E Warrants [Member] | Prefunded Unit [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrents exercise price		3.799
PA Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrents exercise price		$ 3.91
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of common stock warrant			15,300
Number of shares issued		155,038					155,038
Exercise of series A warrants, shares								25,000
Stock issued during period, shares, acquisitions								40,402
Common Stock [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					155,038
Common Stock [Member] | Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of common stock warrant			1,300
Common Stock [Member] | Series E And F Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of common stock warrant										897,594
Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise of series A warrants, shares						25,000

SCHEDULE OF CALCULATIONS OF BAS

SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Income from continuing operations	$ 2,983,861	$ 9,487,884
Deemed dividend		(6,930,335)
Net income continuing operations, numerator, basic computation	2,983,861	2,557,549
Recognition and change in fair value of warrant liabilities	(4,266,231)	(13,992,664)
Net loss continuing operations, numerator, diluted computation	$ (1,282,370)	$ (11,435,115)
Weighted average common shares, basic	1,553,953	980,569
Effect of series B warrants	631,894	214,911
Weighted average common shares, dilutive	2,185,847	1,195,480
Earnings (loss) per common share – basic	$ 1.92	$ 2.61
Earnings (loss) per common share – diluted	$ (0.59)	$ (9.57)

SCHEDULE OF DILUTIVE NET LOSS P

SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARES (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock	10,928	10,928
Series A Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock	113,000	113,000
Series F Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock	2,105,264
Placement Agent Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock	52,632
Unvested Stock Awards [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock	7,709	661
Conversion Of Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to conversion of Series B preferred stock		147,939

SCHEDULE OF FUTURE MINIMUM LEAS

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)	Mar. 31, 2023 USD ($)
Leases
2023	$ 271,267
2024	269,908
2025	144,124
2026	113,738
2027	117,150
Thereafter	151,052
Total undiscounted operating lease payments	1,067,239
Less: Imputed interest	115,753
Present value of operating lease liabilities	$ 951,486

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases
Lease expense	$ 161,614	$ 145,662
Weighted average remaining lease term	3 years 10 months 6 days
Weighted average discount rate	5.60%

SCHEDULE OF EARN-OUT LIABILITY

SCHEDULE OF EARN-OUT LIABILITY (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	$ 2,709,478	$ 3,813,878
Changes due to payments	(1,232,478)	(1,704,925)
Changes due to fair value adjustments	476,692	525
Ending balance	1,953,692	2,709,478
Changes due to business combinations		600,000
Fortman Insurance Agency LLC [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	667,000	515,308
Changes due to payments		(34,430)
Changes due to fair value adjustments	394,467	186,122
Ending balance	1,061,467	667,000
Changes due to business combinations
Southwestern Montana Insurance Center Inc [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	500,000	615,969
Changes due to payments	(250,000)	(326,935)
Changes due to fair value adjustments	150,000	210,966
Ending balance	400,000	500,000
Changes due to business combinations
Altruis Benefits Consultants Inc [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	834,943	992,868
Changes due to payments	(834,943)	(84,473)
Changes due to fair value adjustments	94,225	(73,452)
Ending balance	94,225	834,943
Changes due to business combinations
JP Kush And Associates Inc [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	147,535	1,689,733
Changes due to payments	(147,535)	(1,259,087)
Changes due to fair value adjustments		(283,111)
Ending balance		147,535
Changes due to business combinations
Barra [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance – January 1	560,000
Changes due to payments
Changes due to fair value adjustments	(162,000)	(40,000)
Ending balance	$ 398,000	560,000
Changes due to business combinations		$ 600,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)			3 Months Ended
	Feb. 13, 2023	Feb. 07, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Sep. 13, 2022
Promissory note principle			$ 154,000	$ 0
Common stock par value			$ 0.086		$ 0.086
Repayment of related party debt			$ 412,500	$ 10,770
YES Americana Group LLC [Member]
Promissory note principle		$ 1,845,000				$ 1,500,000
Debt instrument description		On February 7, 2023, the Company and Americana entered into an amendment to the Note pursuant to which (i) the principal amount of the Note was increased to $1,845,000, (ii) the maturity date of the Note was amended to January 15, 2026, (iii) the interest rate under the Note shall not increase after the maturity date, and (iv) the Note can be converted at any time, at the option of Americana, into shares of the Company’s common stock, par value $0.086 per share at an agreed upon conversion price
Common stock par value	$ 0.086	$ 0.086
Conversion of stock	$ 645,000
Conversion of stock shares	66,743
Repayment of related party debt			400,000
Repayment of related party owed			$ 800,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended
	Apr. 30, 2023	Mar. 31, 2023
Subsequent Event [Line Items]
Remaining balance shares		262,684
Subsequent Event [Member]
Subsequent Event [Line Items]
Sale of stock	262,684
Sale of stock	$ 900,000
Remaining balance shares	0